ArticleOncotarget2016

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.

Maristella Bianconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.